Back

Prognosis impact of ticagrelor vs clopidogrel based DAPT discontinuation after acute coronary syndrome. Insights from the multicenter CREA ARIAM Andalucia registry

18 March 2022 (07:45 - 19:55)
Organised by:
Congress Presentation Part of: Acute Coronary Syndromes: Platelets, Lipids, Techniques and Systems Thrombosis, Platelets, and Coagulation ACVC Premium Access ESC Acute CardioVascular Care 2022

About the speaker

Photo
Doctor Gloria Rocio Padilla Rodriguez

University Hospital of Virgen Macarena, Seville (Spain)

7 More presentations in this session

Presentation thumbnail
Acute coronary syndromes in young patients and thrombophilia : the experience of our hospital
Doctor E. Bachlitzanaki (Heraklion, GR)
Abstract Slides Video
Presentation thumbnail
Comparative safety and effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndrome. An on treatment analysis from the multicenter CREA ARIAM Andalucia registry
Mrs B. Hernandez-Meneses (Seville, ES)
Abstract Slides Video
Presentation thumbnail
Can we predict the coronary angiography result?
Doctor M. Santos (Figueira da Foz, PT)
Abstract Slides Video
Presentation thumbnail
Percutaneous coronary intervention for true bifurcation lesions: a single-center experience including the setting of acute coronary syndromes
Doctor M. Brandao (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of anemia in acute coronary syndrome patients
Doctor P. Rocha Carvalho (Vila Real, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute Coronary Syndromes: Platelets, Lipids, Techniques and Systems

The Event

Event poster

ESC Acute CardioVascular Care 2022

18 March - 19 March 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources